The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Multiple Myeloma Treatment Market Research Report 2025

Global Multiple Myeloma Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1933756

No of Pages : 72

Ask Your Query
Synopsis
Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function.
The global Multiple Myeloma Treatment market was valued at US$ 29550 million in 2023 and is anticipated to reach US$ 61790 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
The global Multiple Myeloma market is anticipated to be mainly driven by increase in ageing population, rising obese population, increase in healthcare expenditure and increased penetration of novel cancer drugs. Some of the significant developments of this industry include upcoming new innovative products in the market, trend of combination therapies, and chance of new players.
This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Treatment.
Report Scope
The Multiple Myeloma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Myeloma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiple Myeloma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Roche Holding
Sanofi
Eli Lilly
Novartis
Segment by Type
Proteasome Inhibitors
Immunomodulatory Agents (IMiDs)
Histone Deacetylase (HDAC) Inhibitors
Immunotherapy
Cytotoxic Chemotherapy
Segment by Application
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiple Myeloma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proteasome Inhibitors
1.2.3 Immunomodulatory Agents (IMiDs)
1.2.4 Histone Deacetylase (HDAC) Inhibitors
1.2.5 Immunotherapy
1.2.6 Cytotoxic Chemotherapy
1.3 Market by Application
1.3.1 Global Multiple Myeloma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Treatment Market Perspective (2019-2030)
2.2 Multiple Myeloma Treatment Growth Trends by Region
2.2.1 Global Multiple Myeloma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multiple Myeloma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Multiple Myeloma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Multiple Myeloma Treatment Market Dynamics
2.3.1 Multiple Myeloma Treatment Industry Trends
2.3.2 Multiple Myeloma Treatment Market Drivers
2.3.3 Multiple Myeloma Treatment Market Challenges
2.3.4 Multiple Myeloma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Treatment Players by Revenue
3.1.1 Global Top Multiple Myeloma Treatment Players by Revenue (2019-2024)
3.1.2 Global Multiple Myeloma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Multiple Myeloma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Treatment Revenue
3.4 Global Multiple Myeloma Treatment Market Concentration Ratio
3.4.1 Global Multiple Myeloma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Treatment Revenue in 2023
3.5 Multiple Myeloma Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Treatment Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Treatment Breakdown Data by Type
4.1 Global Multiple Myeloma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Multiple Myeloma Treatment Forecasted Market Size by Type (2025-2030)
5 Multiple Myeloma Treatment Breakdown Data by Application
5.1 Global Multiple Myeloma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Multiple Myeloma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multiple Myeloma Treatment Market Size (2019-2030)
6.2 North America Multiple Myeloma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Multiple Myeloma Treatment Market Size by Country (2019-2024)
6.4 North America Multiple Myeloma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiple Myeloma Treatment Market Size (2019-2030)
7.2 Europe Multiple Myeloma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Multiple Myeloma Treatment Market Size by Country (2019-2024)
7.4 Europe Multiple Myeloma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Multiple Myeloma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiple Myeloma Treatment Market Size (2019-2030)
9.2 Latin America Multiple Myeloma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Multiple Myeloma Treatment Market Size by Country (2019-2024)
9.4 Latin America Multiple Myeloma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Multiple Myeloma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Multiple Myeloma Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Detail
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Multiple Myeloma Treatment Introduction
11.2.4 Roche Holding Revenue in Multiple Myeloma Treatment Business (2019-2024)
11.2.5 Roche Holding Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Multiple Myeloma Treatment Introduction
11.3.4 Sanofi Revenue in Multiple Myeloma Treatment Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Multiple Myeloma Treatment Introduction
11.4.4 Eli Lilly Revenue in Multiple Myeloma Treatment Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Multiple Myeloma Treatment Introduction
11.5.4 Novartis Revenue in Multiple Myeloma Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Multiple Myeloma Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Proteasome Inhibitors
Table 3. Key Players of Immunomodulatory Agents (IMiDs)
Table 4. Key Players of Histone Deacetylase (HDAC) Inhibitors
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Cytotoxic Chemotherapy
Table 7. Global Multiple Myeloma Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Multiple Myeloma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Multiple Myeloma Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Multiple Myeloma Treatment Market Share by Region (2019-2024)
Table 11. Global Multiple Myeloma Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Multiple Myeloma Treatment Market Share by Region (2025-2030)
Table 13. Multiple Myeloma Treatment Market Trends
Table 14. Multiple Myeloma Treatment Market Drivers
Table 15. Multiple Myeloma Treatment Market Challenges
Table 16. Multiple Myeloma Treatment Market Restraints
Table 17. Global Multiple Myeloma Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Multiple Myeloma Treatment Market Share by Players (2019-2024)
Table 19. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Treatment as of 2023)
Table 20. Ranking of Global Top Multiple Myeloma Treatment Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Treatment Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Multiple Myeloma Treatment Revenue Market Share by Type (2019-2024)
Table 28. Global Multiple Myeloma Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Multiple Myeloma Treatment Revenue Market Share by Type (2025-2030)
Table 30. Global Multiple Myeloma Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Multiple Myeloma Treatment Revenue Market Share by Application (2019-2024)
Table 32. Global Multiple Myeloma Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Multiple Myeloma Treatment Revenue Market Share by Application (2025-2030)
Table 34. North America Multiple Myeloma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Multiple Myeloma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Multiple Myeloma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Multiple Myeloma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Multiple Myeloma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Multiple Myeloma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Multiple Myeloma Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Multiple Myeloma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Multiple Myeloma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Multiple Myeloma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Multiple Myeloma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Multiple Myeloma Treatment Product
Table 52. Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2019-2024) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Roche Holding Company Detail
Table 55. Roche Holding Business Overview
Table 56. Roche Holding Multiple Myeloma Treatment Product
Table 57. Roche Holding Revenue in Multiple Myeloma Treatment Business (2019-2024) & (US$ Million)
Table 58. Roche Holding Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Multiple Myeloma Treatment Product
Table 62. Sanofi Revenue in Multiple Myeloma Treatment Business (2019-2024) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Eli Lilly Company Detail
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Multiple Myeloma Treatment Product
Table 67. Eli Lilly Revenue in Multiple Myeloma Treatment Business (2019-2024) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Multiple Myeloma Treatment Product
Table 72. Novartis Revenue in Multiple Myeloma Treatment Business (2019-2024) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Multiple Myeloma Treatment Market Share by Type: 2023 VS 2030
Figure 3. Proteasome Inhibitors Features
Figure 4. Immunomodulatory Agents (IMiDs) Features
Figure 5. Histone Deacetylase (HDAC) Inhibitors Features
Figure 6. Immunotherapy Features
Figure 7. Cytotoxic Chemotherapy Features
Figure 8. Global Multiple Myeloma Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Multiple Myeloma Treatment Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 13. Multiple Myeloma Treatment Report Years Considered
Figure 14. Global Multiple Myeloma Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Multiple Myeloma Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Multiple Myeloma Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Multiple Myeloma Treatment Market Share by Players in 2023
Figure 18. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Multiple Myeloma Treatment Revenue in 2023
Figure 20. North America Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Multiple Myeloma Treatment Market Share by Country (2019-2030)
Figure 22. United States Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Multiple Myeloma Treatment Market Share by Country (2019-2030)
Figure 26. Germany Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Multiple Myeloma Treatment Market Share by Region (2019-2030)
Figure 34. China Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Multiple Myeloma Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Multiple Myeloma Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Multiple Myeloma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Treatment Business (2019-2024)
Figure 49. Roche Holding Revenue Growth Rate in Multiple Myeloma Treatment Business (2019-2024)
Figure 50. Sanofi Revenue Growth Rate in Multiple Myeloma Treatment Business (2019-2024)
Figure 51. Eli Lilly Revenue Growth Rate in Multiple Myeloma Treatment Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Multiple Myeloma Treatment Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock